APOE and Cognitive impairment: In the DeadLowADnp competing risk group, there was a significant interaction between APOE4 and cognitive impairment (SHR = 0.401, 95% CI 0.314–0.512; CSHR = 0.433, 95% CI 0.337–0.556).